Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
33,945,050
-
Total 13F shares
-
25,729,728
-
Share change
-
+1,818,320
-
Total reported value
-
$100,585,169
-
Put/Call ratio
-
69%
-
Price per share
-
$3.91
-
Number of holders
-
72
-
Value change
-
+$1,208,054
-
Number of buys
-
35
-
Number of sells
-
18
Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) as of Q3 2024
As of 30 Sep 2024 Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,729,728 shares of stock of the company.
Largest 10 holders included 5AM Venture Management, LLC, Versant Venture Management, LLC, SPHERA FUNDS MANAGEMENT LTD., BAKER BROS. ADVISORS LP, Altium Capital Management LP, BlackRock, Inc., Schonfeld Strategic Advisors LLC, Ensign Peak Advisors, Inc, VANGUARD GROUP INC, and Driehaus Capital Management LLC.
This table shows 72 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.